Showing results (2351-2360 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|November 6, 2018
MNK1 inhibitor as an antiviral agent suppresses buffalopox virus protein synthesisRam Kumar, Nitin Khandelwal, Yogesh Chander, et al.Antiviral Research|March 31, 2019
Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancerLukai Zhai, Rashi Yadav, Nitesh K Kunda, et al.Antiviral Research|April 11, 2017
Early phase dynamics of traceable mCherry fluorescent protein-carrying HIV-1 infection in human peripheral blood mononuclear cells-transplanted NOD/SCID/Jak3-/- miceNobuyo Higashi-Kuwata, Hiromi Ogata-Aoki, Shin-Ichiro Hattori, et al.Antiviral Research|April 1, 1988
Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyraseM Portolani, P Pietrosemoli, C Cermelli, et al.Antiviral Research|July 15, 2019
Meeting report: 32nd International Conference on Antiviral ResearchEnzo Tramontano, Bart Tarbet, Jessica R Spengler, et al.Antiviral Research|July 15, 2019
BAY 41-4109-mediated aggregation of assembled and misassembled HBV capsids in cells revealed by electron microscopyVirgile Rat, Florian Seigneuret, Julien Burlaud-Gaillard, et al.Antiviral Research|April 7, 2019
Identification of a clinical compound losmapimod that blocks Lassa virus entryXiaoyu Zhang, Feihu Yan, Ke Tang, et al.Antiviral Research|January 18, 2017
Short-term clinical safety profile of brincidofovir: A favorable benefit-risk proposition in the treatment of smallpoxGreg Chittick, Marion Morrison, Thomas Brundage, et al.Antiviral Research|November 12, 2016
Amending Koch's postulates for viral disease: When "growth in pure culture" leads to a loss of virulenceJoseph Prescott, Heinz Feldmann, David SafronetzAntiviral Research|November 15, 2016
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoVWilliam J Liu, Min Zhao, Kefang Liu, et al.Pageof 523